Impact of COVID-19 on healthcare for patients with diabetes
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group considers how the standard of healthcare for patients with diabetes is impacted by COVID-19.
Blood pressure medicines do not increase chance of COVID-19 death
Though heart damage plays a role in how someone deals with COVID-19, researchers at the American Heart Association found that blood pressure medicines don't impact your chances.
Britain’s obesity plan: The top three ways we can transform our health
Stephen Jones, CEO and Co-Founder at Nourish Fit Food, discusses how Britain's obesity plan will continue to fail unless the concept of health itself is radically redefined.
Are unreported falls the missing data key to improving elderly care?
Barak Katz, General Manager at Essence Smartcare, reveals how the information we currently aren’t collecting could revolutionise the effect falls have on the victims and their care networks.
Healthcare in the post-Brexit era
With only 2 months to go, Nicholas Kelly, CEO, Axela Ltd, discusses what needs to be done now in order to prepare healthcare services for the post-Brexit era.
Applications for the second round of the AI in Health and Care Award open
The NHS has announced that applications for the second round of the AI in Health and Care Award are now open.
First whole city COVID-19 testing to launch in Liverpool
In the first pilot of whole city testing, residents and workers in Liverpool will be offered COVID-19 testing, whether they have symptoms or not.
Hospital floors are a breeding ground for bacteria
Findings from a new study have cites that hospital floors are a hotspot for bacteria to breed, creating a route of transfer to patients.
Black communities to receive COVID-19 information via new app
A cardiologist from the University of Cincinnati is partnering with researchers in St. Louis and rural Georgia to develop a smartphone app that will deliver COVID-19 information and education to Black communities.
Decrease in US health insurance coverage led to 25,180 deaths
US health insurance coverage decreased significantly, resulting in 25,180 excess deaths before COVID - researchers say this number will triple if the Affordable Care Act is overturned.
Commission launches additional measures to limit the spread of COVID-19
The European Commission is launching an additional set of actions to help limit the spread of the coronavirus and save lives.
NHS saves millions on highly effective stroke drugs
Researchers from the Health Economics Unit and University of Leeds looked at the cost of treating strokes and found that the drugs prescribed are so effective they save the NHS money.
The ignored healthcare perspective of people with disabilities
A new study in the US shows that people with disabilities view healthcare as a human right and believe that this perspective does translate to policy-makers.
When is the UK COVID-19 vaccine going to be ready?
While AstraZeneca and Oxford University continue to work on a UK COVID-19 vaccine, what about the rest of the world?
Novel biomarkers predict response to rheumatoid arthritis treatment
A new study, led by researchers at Queen Mary University of London, uses novel biomarkers to predict patient responsiveness to rheumatoid arthritis treatment.
Study finds antibody response to COVID-19 reduces over time
The largest at-home antibody study for COVID-19 has found that the number of people with antibodies fell by 26.5% after infection.
US healthcare: Black people less likely to receive lung cancer chemotherapy
Boston Medical Center researchers found that Black individuals, above all other racial groups, are less likely to receive lung cancer chemotherapy.
Child influencers promote unhealthy food on YouTube channels
Researchers at NYU School of Global Public Health and NYU Grossman School of Medicine have warned against the dangers of child influences promoting unhealthy food and drinks on their YouTube channels.
US healthcare: 34% of older people could be prescribed the wrong drugs
A new study found that it costs patients over $450 a year when they are prescribed the wrong drugs, making them twice as likely to go to hospital.
Are remote GP consultations here to stay?
Dr Owain Rhys Hughes, founder and CEO of Cinapsis, explores how remote GP consultations are providing opportunities for both patients and the NHS.
